Skip to Main Content

The drug industry, with encouragement from the Food and Drug Administration, is advancing efforts to modernize clinical trials, streamlining the process of figuring out whether a treatment actually works.

STAT’s national biotech reporter Damian Garde delved into new approaches, examined case studies, and fielded questions about the future of clinical trials.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!